Bon Secours Mercy Health, a large multi-state hospital group in selling a majority interest in a subsidiary that does revenue cycle management to a PE firm.
Phillo Health, which offers a digital assistant platform to monitor and communicate with patients in their homes, has bedded down a comfy $11 million in new capital.
Apple polishes up its health industry offerings, buying asthma monitoring firm Tueo Health for an undisclosed sum. The large tech firms continue to show an interest in figuring out how to play in health care.
EvidenceCare, a vendor of clinical decision support and revenue optimization (i.e., upcoding) software for hospitals, evidently is cared for by investors, hustling up a fresh $7.3 million in financing.
Dario Health, a maker of devices and software to track diabetes care and other chronic conditions., has gone public, raising a measly $7.2 million. I can't for the life of me understand how desperate you must be to go through the hassle of being public for such a small amount of capital.
Children's behavioral health company Mightier gets stronger with an infusion of $6.6 million in capital. Hope I won't be writing soon about how the Mightier have fallen.
Health at Scale gets a weighty $16 million round of financing, all coming from the Optum division of UnitedHealth, to fund its artificial intelligence software to match patients with treatments.
Financial giant JP Morgan is acquiring InstaMed, which helps providers collect cost-sharing amounts from patients and coordinates payments with insurers. The price is supposedly around $500 million.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.